Centenial Surgical Suture Limited is an India-based company, which is engaged in the development, manufacturing and supply of medical devices. The Company operates through the Medical Devices segment. The Company's products include absorbable sutures, non-absorbable sutures, superior atraumatic needles, cardiovascular sutures, and other medical devices. Its absorbable sutures consist of catgut, centicryl, centicryl rapid, centisorb, centisorb rapid, centisorb tri-plus +, centisynth, and monosynth. Its non-absorbable sutures consist of centibond, centidene, centilene, centisilk, centlon, and centsteel. Its superior atraumatic needles consist of centibond, centiiwax, centilene, and centsteel. Its other medical devices include centipunch, centcel, centiitape, centiiwax, centipace, centipled, and disposable skin stapler close.
CENTENIAL SURGICAL SUTURE LTD. Financial Highlights
- Revenue: CENTENIAL SURGICAL SUTURE LTD. reported revenue of ₹54.01 crore in FY26 vs ₹53.64 crore in FY25. It showed an increase of 0.69% on a yearly basis.
- Operating Profit: CENTENIAL SURGICAL SUTURE LTD. reported an operating loss of ₹2.08 crore in FY26 vs ₹1.62 crore in FY25. It showed a decrease of 28.40% on a year-on-year basis.
- Net Profit: CENTENIAL SURGICAL SUTURE LTD. reported a net loss of ₹2.20 crore in FY26 vs ₹1.46 crore in FY25. It showed a decrease of 50.68% on a yearly basis.
CENTENIAL SURGICAL SUTURE LTD. Quarterly Result Highlights
- CENTENIAL SURGICAL SUTURE LTD. reported revenue of ₹12.65 crore in Mar 2026, compared with ₹14.91 crore in Dec 2025, representing a decrease of 15.16% on a quarter-on-quarter (QoQ) basis.
- CENTENIAL SURGICAL SUTURE LTD. reported an operating loss of ₹2.23 crore in Mar 2026, compared with ₹0.20 crore in Dec 2025, representing a decrease of 1,215.00% on a quarter-on-quarter (QoQ) basis.
- CENTENIAL SURGICAL SUTURE LTD. reported a loss of ₹2.31 crore in Mar 2026, compared with ₹0.15 crore in Dec 2025, reflecting a decrease of 1,640.00% on a QoQ basis.
- The earnings per share (EPS) of CENTENIAL SURGICAL SUTURE LTD. stood at ₹4.01 during Mar 2026.